Revvity, Inc. (RVTY)
Sector: Technology
Industry: Laboratory Analytical Instruments
Country: United States
Exchange: NYSE
Market cap: $16.37B
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
Latest financial period: July 5, 2026
Filed with the SEC: August 11, 2026
Estimated earnings date: October 26, 2026
Profit #1166 of 1484 companies
| | Jul 26 | Apr 26 | Dec 25 | Sep 25 |
|---|
| ROIC | 3.4% | 3.3% | 3.2% | 3.1% |
Growth #1102 of 1484 companies
Payout #1011 of 1484 companies
Safety #48 of 1484 companies
Price #1071 of 1484 companies
